Ravi V J Chari

This inventor holds 94 USPTO granted patents and 5 published patent applications, plus 6 CIPO patents and 9 EPO patents, primarily in Cytotoxic Compounds (CPC class C07D487-04). Top assignees: Immunogen, Inc., Sanofi-Aventis, Aventis Pharma S.a.. Active years: 2002-2024.

USPTO Granted Patents = 94 (Patent Applications = 5)

% Patents Active = 58.5

CIPO Patents = 6

EPO Patents = 9 (Patent Applications = 17)

Average Co-Inventor Count = 2.6

ph-index = 27

Forward Citations = 3,089(Granted Patents)

Forward Citations (Not Self Cited) = 2,782(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Waltham, MA (US) (2013)
Newton, MA (US) (2002 - 2024)

Company Filing History:

Years Active: 2002-2024

Loading Chart...

Areas of Expertise:

Cytotoxic Agents

Benzodiazepine Derivatives

Antibody-Drug Conjugates

Cell-Binding Agents

Cross-Linkers

Camptothecin Derivatives

Maytansinoid Conjugates

Conjugation Methods

Proliferative Disorders

Hydrophilic Linkers

Ansamitocin Derivatives

Specific Cell Targeting

94 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49918 - Cytotoxic benzodiazepine derivatives (2024-04-16),

2. 11793885 - Substituted benzo[5,6][1,4]diazepino[1,2-a]indoles for the treatment of proliferative disorders (2023-10-24),

3. 11732038 - Conjugates comprising cell-binding agents and cytotoxic agents (2023-08-22),

4. 11505617 - Benzodiazepine derivatives (2022-11-22),

5. 11229639 - Camptothecin derivatives (2022-01-25),

6. 11116845 - Cytotoxic benzodiazepine derivatives (2021-09-14),

7. 11046762 - Cross-linkers and their uses (2021-06-29),

8. 10988531 - Conjugates comprising cell-binding agents and cytotoxic agents (2021-04-27),

9. 10947315 - Benzodiazepine derivatives (2021-03-16),

10. 10844135 - Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said (2020-11-24),

11. 10722588 - Cytotoxic benzodiazepine derivatives (2020-07-28),

12. 10570212 - Cytotoxic benzodiazepine derivatives (2020-02-25),

13. 10494431 - Cross-linkers and their uses (2019-12-03),

14. 10238751 - Cytotoxic benzodiazepine derivatives (2019-03-26),

15. 10233257 - Methods for preparing antibody-drug conjugates (2019-03-19),

Title: The Innovative Journey of Ravi V J Chari

Introduction: Ravi V J Chari, a visionary inventor based in Newton, MA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Ravi V J Chari holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for problem-solving, Ravi V J Chari has had a successful career working in various tech companies before venturing into entrepreneurship to pursue his own inventions.

Collaborations: Throughout his career, Ravi V J Chari has collaborated with leading researchers, engineers, and scientists to bring his ideas to life, fostering a culture of innovation and creativity in the projects he undertakes.

Conclusion: Ravi V J Chari's relentless pursuit of innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions, inspiring the next generation of inventors to dream big and create change.